Neonatal hyperthyroidism: Neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy

被引:1
作者
Zuppa, A. A. [1 ]
Sindico, P. [1 ]
Savarese, I. [1 ]
D'Andrea, V. [1 ]
Fracchiolla, A. [1 ]
Cota, F. [1 ]
Romagnoli, C. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Pediat, Div Neonatol, I-00168 Rome, Italy
关键词
newborn; hyperthyroidism; antibodies; thyrotropin receptors; Graves' disease; thyroidectomy; Lugol's solution; propylthiouracil; CONGENITAL HYPERTHYROIDISM; FETAL; IMMUNOGLOBULIN; RECEPTOR; THYROTOXICOSIS; PREGNANCY; THERAPY; GLAND;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: About 1-2% of infants born to mothers with Graves' disease or Hashimoto's thyroiditis develop neonatal hyperthyroidism because of transplacental passage of IgG stimulating TSH receptors (TRAb). Objective: To evaluate the effect of maternal total thyroidectomy on neonatal clinical course. Methods: We describe two brothers born to it mother with Graves' disease, before and after total thyroidectomy. Results: The first child showed persistent tachycardia, the presence of TRAb and a laboratory pattern of hyperthyroidism. Lugol's solution was started and then propylthiouracil was added. Digitalis, furosemide and diazepam were necessary for treatment of heart failure, hypertension and irritability. On the 70(th) day of life, hormone serum levels normalized and treatment was interrupted. TRAb normalized by the third month of life. The second infant was born 2 years after the mother underwent total thyroidectomy. In spite of a laboratory pattern of hyperthyroidism and positivity to TRAb, he showed only considerable weight loss, and no therapy was required. Conclusions: TRAb may persist after total thyroidectomy: clinical and instrumental follow-up of the newborn is recommended.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 24 条
[1]  
Borrás-Pérez MV, 2001, J PEDIATR ENDOCR MET, V14, P1169
[2]  
CAVALLO L, 1994, RIV ITAL PED, V20, P75
[3]   A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism [J].
DeRoux, N ;
Polak, M ;
Couet, J ;
Leger, J ;
Czernichow, P ;
Milgrom, E ;
Misrahi, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2023-2026
[4]   Iopanoic acid in the management of neonatal graves' disease [J].
Earles S.M. ;
Gerrits P.M. ;
Transue D.J. .
Journal of Perinatology, 2004, 24 (2) :105-108
[5]  
FISHER DA, 1990, CLIN PEDIAT ENDOCRIN, P114
[6]   CONGENITAL GRAVES-DISEASE - 4 FAMILIAL CASES WITH LONG-TERM FOLLOW-UP AND PERSPECTIVE [J].
HOLLINGSWORTH, DR ;
MABRY, CC .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1976, 130 (02) :148-155
[7]   Thyroid disease in relation to pregnancy: A decade of change [J].
Lazarus, JH ;
Kokandi, A .
CLINICAL ENDOCRINOLOGY, 2000, 53 (03) :265-278
[8]   Management of Graves' disease during pregnancy:: The key role of fetal thyroid gland monitoring [J].
Luton, D ;
Le Gac, I ;
Vuillard, E ;
Castanet, M ;
Guibourdenche, J ;
Noel, M ;
Toubert, ME ;
Léger, J ;
Boissinot, C ;
Schlageter, MH ;
Garel, C ;
Tébeka, B ;
Oury, JF ;
Czernichow, P ;
Polak, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6093-6098
[9]   Efficacy of oral iodide therapy on neonatal hyperthyroidism caused by maternal Graves' disease - A case report [J].
Maragliano, G ;
Zuppa, AA ;
Florio, MG ;
Scapillati, ME ;
Girlando, P ;
Crescimbini, B ;
Cafforio, C ;
Noia, G ;
Cavaliere, AF ;
Tortorolo, G .
FETAL DIAGNOSIS AND THERAPY, 2000, 15 (02) :122-126
[10]   FETAL AND NEONATAL HYPERTHYROIDISM AND HYPOTHYROIDISM DUE TO MATERNAL TSH RECEPTOR ANTIBODIES [J].
MCKENZIE, JM ;
ZAKARIJA, M .
THYROID, 1992, 2 (02) :155-159